HRT Financial’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,179
| Closed | -$572K | – | 2925 |
|
|
2025
Q1 | $572K | Buy |
+5,179
| New | +$572K | ﹤0.01% | 1211 |
|
|
2024
Q4 | – | Sell |
-44,395
| Closed | -$5.12M | – | 2716 |
|
|
2024
Q3 | $5.12M | Buy |
+44,395
| New | +$5.12M | 0.03% | 421 |
|
|
2024
Q2 | – | Sell |
-41,993
| Closed | -$5.79M | – | 2609 |
|
|
2024
Q1 | $5.79M | Buy |
41,993
+22,347
| +114% | +$3.08M | 0.04% | 222 |
|
|
2023
Q4 | $2.59M | Sell |
19,646
-57,117
| -74% | -$7.52M | 0.02% | 510 |
|
|
2023
Q3 | $8.64M | Buy |
+76,763
| New | +$8.64M | 0.09% | 151 |
|
|
2022
Q4 | – | Sell |
-19,599
| Closed | -$2.08M | – | 2691 |
|
|
2022
Q3 | $2.08M | Sell |
19,599
-24,311
| -55% | -$2.58M | 0.02% | 563 |
|
|
2022
Q2 | $4.28M | Buy |
43,910
+30,061
| +217% | +$2.93M | 0.05% | 295 |
|
|
2022
Q1 | $1.3M | Sell |
13,849
-9,196
| -40% | -$862K | 0.01% | 778 |
|
|
2021
Q4 | $1.96M | Buy |
23,045
+884
| +4% | +$75.3K | 0.01% | 592 |
|
|
2021
Q3 | $2.13M | Buy |
22,161
+14,306
| +182% | +$1.37M | 0.01% | 621 |
|
|
2021
Q2 | $764K | Buy |
+7,855
| New | +$764K | 0.01% | 1272 |
|
|
2021
Q1 | – | Sell |
-3,456
| Closed | -$331K | – | 2775 |
|
|
2020
Q4 | $331K | Buy |
+3,456
| New | +$331K | 0.01% | 1170 |
|
|
2019
Q4 | – | Sell |
-2,322
| Closed | -$209K | – | 1396 |
|
|
2019
Q3 | $209K | Sell |
2,322
-3,386
| -59% | -$305K | 0.01% | 1019 |
|
|
2019
Q2 | $481K | Buy |
+5,708
| New | +$481K | 0.03% | 404 |
|